Quasar Medical

What Quasar Medical does

Quasar Medical is a global Contract Development and Manufacturing Organization (CDMO) that designs, develops, prototypes, and manufactures minimally invasive medical devices for medical device original equipment manufacturers (OEMs). Founded in 1988 in Israel by Boaz Amitai and now headquartered in Singapore, the company operates 11 facilities across the United States, Mexico, Ireland, Israel, Singapore, China, Thailand, Japan, and Hong Kong, with a workforce of 5,000+ employees globally. Quasar produces more than 7 million medical devices and assemblies and 4 million electromagnetic (EM) sensors annually, holding ISO 13485:2016 certification across multiple facilities and FDA registrations for sites in China, Thailand, and Singapore, along with China NMPA/MAH compliance for local commercialization.

The company's product and capability platform spans medical balloon catheters (semi-compliant, non-compliant, bladed, perfusion, and multi-lumen designs in 1.5mm to 38mm diameters), braided catheter shafts (2Fr to 22Fr), EM sensor development in 5DOF and 6DOF configurations for catheter navigation, Nitinol processing (laser cutting, shape setting, surface processing, passivation), and complex micro-assembly for interventional cardiology, neurovascular, structural heart, electrophysiology, gastroenterology, and advanced therapy applications. The offering is sold as an integrated 'design-to-commercialization' service, supported by innovation hubs in Galway, Ireland (46,000 ft²) and San Diego (10,000 ft² post-Medres acquisition), and high-volume manufacturing hubs in Tecate, Mexico (95,000 ft²) and three Chonburi, Thailand facilities.

Quasar generates revenue through contract manufacturing services and unit-based production contracts with enterprise medical device OEMs, using quote-based pricing tailored to device complexity, production volume, regulatory requirements, and geographic manufacturing location under multi-year agreements. The company is privately held by Singapore-based private equity firm Boyu Capital, which acquired it in 2023 following Longreach Group's 2019 majority stake acquisition. Under PE ownership, Quasar has pursued an aggressive inorganic growth strategy, completing acquisitions of Creganna Singapore (2021), Ridgeback Technologies (2024), Nordson Medical's Galway and Tecate facilities (2025), and Medres International's Nitinol Design and Development Center (2026), while expanding the Thailand footprint and launching the Singapore Global Headquarters in 2025.

Name

Quasar Medical

Legal name

Quasar Medical

Website

https://quasarmedical.com

Company type

Private

Founded year

1988

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Quasar Medical is a Singapore-headquartered global CDMO founded in 1988 that designs and manufactures minimally invasive medical devices, including catheters, balloons, EM sensors, and Nitinol components, for medical device OEMs across 11 facilities and 5,000+ employees worldwide.

Ownership category

akta.pro rank

Headquarters

HQ city

Saint Paul

HQ country

United States

HQ region

North America

Offices12 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain

Revenue model

1. Contract Manufacturing Services: Quasar Medical operates as a CDMO providing design, development, prototyping, and manufacturing services for medical device OEMs. Revenue is generated through service contracts for concept-to-commercialization solutions, including advanced product development, prototyping, and scalable manufacturing.
2. Device Assembly & Production: High-volume manufacturing of medical devices and assemblies, producing more than 7 million medical devices and assemblies annually. Revenue generated through unit-based production contracts.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Core offering

Quasar Medical is a global Contract Development and Manufacturing Organization (CDMO) that designs, develops, prototypes, and manufactures complicated minimally invasive medical devices, including medical balloons, catheters, EM-micro sensors, Nitinol components, and finished device assemblies. The company provides turnkey concept-to-commercialization solutions for medical device OEMs across interventional therapies such as cardiovascular, neurovascular, structural heart, and electrophysiology.

Product overview

Quasar Medical is a global Contract Development and Manufacturing Organization (CDMO) providing end-to-end solutions for minimally invasive medical devices. The company's platform integrates multiple core capabilities: Medical Balloons and Catheters (including bladed, perfusion, and multi-lumen designs), EM Sensor Development (5DOF and 6DO F configurations), Nitinol Solutions, Components & Device Manufacturing, Rapid Prototyping, and Assembly Solutions. The portfolio includes facilities like the Galway, Ireland Innovation Hub for concept development and the Tecate, Mexico Manufacturing Hub for high-volume production. Quasar serves medical device OEMs across interventional therapies including cardiovascular, neurovascular, structural heart, and electrophysiology, offering integrated services from initial concept through commercial-scale manufacturing.

Differentiator

Problem solved

Functional benefit

Products and services

• Medical Balloons and Catheters
• EM Sensor Development
• Nitinol Solutions
• Design to Commercialization
• Components & Device Manufacturing
• Rapid Prototyping
• Assembly Solutions

Quantifiable outcome

• Producing over 4 million EM sensors annually
• +3 more outcomes

Named customers3 records

Segments5 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Four partnerships are on record, tiered core.

• Medres InternationalcoreStrategic or Co-development Partner · 5 August 2026Quasar Medical acquired Medres International's Nitinol Design and Development Center in San Diego, California (10,000 ft² facility established in 2024). The acquisition brings world-class expertise including Tom Duerig (who introduced Nitinol to medical devices as founder of NDC) and integrates the San Diego site into Quasar's global network spanning facilities in Israel, Ireland, Mexico, and Thailand.
• Nordson Corporation (Medical Business)coreStrategic or Co-development Partner · 2 September 2025Quasar Medical acquired Nordson Corporation's design and development contract manufacturing businesses in Galway, Ireland, and Tecate, Mexico. The acquisition adds nearly 200 employees and two FDA-registered, ISO 13485-certified facilities to Quasar's global CDMO platform, positioning the company as a fully integrated provider of concept-to-commercialization solutions.
• Nordson Medical Contract Manufacturing UnitcoreStrategic or Co-development Partner · 1 May 2025Quasar Medical acquired Nordson's contract manufacturing unit in May 2025 as part of market expansion. This transaction was highlighted in DelveInsight's medical device contract manufacturing market report alongside other key industry transactions.
• Ridgeback TechnologiescoreStrategic or Co-development Partner · 25 September 2024Quasar Medical acquired Ridgeback Technologies, a maker of catheter balloons, to enhance its portfolio of minimally invasive medical devices. The acquisition expands Quasar's manufacturing capabilities and presence in Galway, Ireland, adding innovative balloon technology and manufacturing capabilities.

Scale indicators7 records

Recent moves9 records

Expansion highlights6 records

Direct peers

• Integer Holdings Corporation: Large US-listed medical device contract manufacturer and OEM with similar exposure to interventional cardiology, cardio and vascular catheters, and orthopedics. Closest direct competitor in medical device CDMO with comparable end-to-end capabilities.
• Tegra Medical: Medical device contract manufacturer specializing in precision machining, metal stamping, and complex assemblies for interventional and surgical devices. Directly comparable to Quasar's micro-assembly and components business.
• Viant Medical: US-focused medical device contract manufacturer serving orthopedics, minimally invasive surgery, and interventional device OEMs. Comparable in CDMO business model and target customer profile.
• Creation Technologies: Medical-focused EMS and CDMO serving interventional, diagnostic, and therapeutic device OEMs. Comparable in end-to-end manufacturing services and FDA-regulated production.
• Nordson Medical: Medical device CDMO with balloon, catheter, and sensor capabilities. Quasar acquired Nordson's Galway and Tecate contract manufacturing businesses in 2025, indicating direct product overlap.
• Providien: Medical device contract manufacturer specializing in precision metal and plastic components, sub-assemblies, and finished devices for interventional and surgical OEMs. Comparable services and customer base.
• Freudenberg Medical: Global medical device CDMO offering complex catheters, balloons, hypotubes, and minimally invasive components. Directly comparable in product portfolio and customer base to Quasar's balloon and catheter business.
• TE Connectivity (Creganna Medical): TE Connectivity operates Creganna Medical, a catheter and minimally invasive device CDMO. Highly comparable to Quasar's catheter business; Quasar acquired Creganna's Singapore operation from TE in 2021.

Broad incumbents

• Flex (Flextronics) Medical: Global EMS giant with a medical device segment serving diagnostics, monitoring, and therapeutic OEMs. Overlapping in medical device manufacturing but with much broader product portfolio and customer base.
• Jabil Healthcare: Large diversified EMS provider with a significant healthcare and medical device manufacturing business serving instrumentation, diagnostic, and therapeutic OEMs. Broader scale but overlapping medical device CDMO capabilities.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/quasar-medical-manufacturing

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Subsidiaries5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Quasar Medical